This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Ucb Pharma, S.a.. Active years: 2008-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2010
Title: Karen Zinkewich-Peotti: Innovator in Biological Products
Introduction
Karen Zinkewich-Peotti is a prominent inventor based in Berkshire, GB. She has made significant contributions to the field of biological products, particularly in the development of antibody molecules. With a total of 2 patents, her work has implications for the treatment of diseases related to VEGF and KDR.
Latest Patents
Her latest patents disclose antibody molecules that contain at least one CDR derived from a mouse monoclonal antibody with specificity for human KDR. Additionally, she has developed a CDR grafted antibody wherein at least one of the CDRs is a hybrid CDR. The patents also include DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells, and the uses of these antibody molecules in treating diseases associated with VEGF and/or KDR.
Career Highlights
Karen Zinkewich-Peotti is currently associated with UCB Pharma, S.A., where she continues to advance her research in biological products. Her innovative work has positioned her as a key figure in her field.
Collaborations
Some of her notable coworkers include Andrew George Popplewell and Simon Peter Tickle, who have collaborated with her on various projects.
Conclusion
Karen Zinkewich-Peotti's contributions to the field of biological products highlight her role as an influential inventor. Her patents and ongoing research continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile